• 184AA3: a xenograft model of ER+ breast adenocarcinoma
    with W. C. Hines, I. Kuhn, K. Thi, B. Chu, G. Stanford-Moore, R. Sampayo, M. Stampfer, A. D. Borowsky, and M. J. Bissell
    © 2015 Springer Science+Business Media New York Despite the prevalence and significant morbidity resulting from estrogen receptor positive breast adenocarcinomas, there are only a few models of this cancer subtype available for drug development and arguably none for studying etiology. Those models that do exist have questionable clinical relevance. Given our goal of developing luminal models, we focused on six cell lines derived by minimal mutagenesis from normal human breast cells, and asked if…Read more